Trial Profile

Phase II Study Assessing Efficacy and Safety of NFL-101 on Reduction of Reinforcing Properties of Cigarettes (PRECESTO Trial)

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 23 Oct 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs NFL 101 (Primary)
Indications Smoking withdrawal
Focus Proof of concept; Therapeutic Use
Acronyms PRECESTO; PRECESTO Trial
Sponsors Smoke Free Therapeutics

Most Recent Events

18 Oct 2023 Status changed from active, no longer recruiting to completed.
21 Jun 2023 According to a NFL Biosciences media release, the scientific advice company asked previously from EMA through its marketing authorization was issued on June 20, 2023.
09 May 2023 According to NFL media release, initial results are expected in the Q3 of 2023.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com